Filing Flows › Bioventus (BVS) › Operating margin
Bioventus (BVS) operating margin by quarter
Bioventus' operating margin was 6.8% in Q3 2026 (third quarter 2026), -5.7 pts from Q2 2026. Over the last 6 quarters it ranged from 6.4% (Q1 2026) to 12.5% (Q2 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 6.8% | -5.7 pts | -1.3 pts |
| Q2 2026 | 12.5% | +6.1 pts | +0.0 pts |
| Q1 2026 | 6.4% | -6.0 pts | — |
| Q4 2025 | 12.3% | +4.2 pts | — |
| Q3 2025 | 8.1% | -4.3 pts | — |
| Q2 2025 | 12.4% | — | — |
Q3 2026 at a glance
Bioventus, Q3 2026: revenue $142M (+3% year over year), operating margin 6.8%, net earnings $6.0M, operating cash flow $20.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Bioventus' operating margin?
Bioventus' operating margin was 6.8% in Q3 2026 (third quarter 2026), -5.7 pts from Q2 2026.
How has Bioventus' operating margin changed?
Over the last 6 quarters it ranged from 6.4% (Q1 2026) to 12.5% (Q2 2026).